Zhenping Chen

2.9k total citations
147 papers, 1.7k citations indexed

About

Zhenping Chen is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Zhenping Chen has authored 147 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 27 papers in Molecular Biology and 24 papers in Genetics. Recurrent topics in Zhenping Chen's work include Platelet Disorders and Treatments (58 papers), Hemophilia Treatment and Research (36 papers) and Blood groups and transfusion (26 papers). Zhenping Chen is often cited by papers focused on Platelet Disorders and Treatments (58 papers), Hemophilia Treatment and Research (36 papers) and Blood groups and transfusion (26 papers). Zhenping Chen collaborates with scholars based in China, United States and Canada. Zhenping Chen's co-authors include Runhui Wu, Renchi Yang, Ya Cai, Mehran Haidari, J. Phillipson, Yifei Wang, Zeping Zhou, Thomas Albrecht, Alexander Kurosky and Dongsheng Gu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Zhenping Chen

132 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenping Chen China 25 500 454 240 215 169 147 1.7k
Konradin Metze Brazil 26 551 1.1× 373 0.8× 235 1.0× 350 1.6× 184 1.1× 142 2.3k
Colin Longstaff United Kingdom 30 739 1.5× 980 2.2× 462 1.9× 327 1.5× 205 1.2× 96 3.0k
Akira Hayakawa Japan 25 815 1.6× 249 0.5× 204 0.8× 164 0.8× 191 1.1× 142 2.2k
Takeshi Sasaki Japan 28 729 1.5× 321 0.7× 471 2.0× 165 0.8× 131 0.8× 178 2.8k
Rongrong Liu China 21 580 1.2× 135 0.3× 395 1.6× 127 0.6× 149 0.9× 130 1.6k
Na Wang China 27 1.0k 2.1× 206 0.5× 269 1.1× 255 1.2× 181 1.1× 191 2.7k
Takashi Sugihara Japan 28 796 1.6× 626 1.4× 222 0.9× 114 0.5× 546 3.2× 229 3.0k
Claire Summers United Kingdom 7 1.1k 2.2× 282 0.6× 201 0.8× 183 0.9× 264 1.6× 12 2.6k
S. Moore United States 20 663 1.3× 653 1.4× 406 1.7× 100 0.5× 144 0.9× 53 2.4k
Jacob Odeberg Sweden 31 1.3k 2.5× 350 0.8× 828 3.5× 336 1.6× 131 0.8× 99 3.3k

Countries citing papers authored by Zhenping Chen

Since Specialization
Citations

This map shows the geographic impact of Zhenping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenping Chen more than expected).

Fields of papers citing papers by Zhenping Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenping Chen. The network helps show where Zhenping Chen may publish in the future.

Co-authorship network of co-authors of Zhenping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenping Chen. A scholar is included among the top collaborators of Zhenping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenping Chen. Zhenping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Gu, Hao, et al.. (2024). HIF-1α induced by hypoxic condition regulates Treg/Th17 axis polarization in chronic immune thrombocytopenia. International Immunopharmacology. 131. 111810–111810. 7 indexed citations
4.
Chen, Zhenping, Guoqing Liu, Gang Li, et al.. (2024). Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center. Pediatric Investigation. 8(4). 244–252.
5.
Wang, Zhifa, et al.. (2024). The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China. British Journal of Haematology. 205(1). 300–305. 1 indexed citations
6.
Li, Zekun, Heng Zhang, Zhenping Chen, et al.. (2024). Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial. Research and Practice in Thrombosis and Haemostasis. 9(1). 102639–102639. 1 indexed citations
7.
8.
Liu, Shuguang, Boshi Wang, Chao Gao, et al.. (2023). USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis. Blood Advances. 7(13). 3099–3112. 11 indexed citations
9.
Wang, Zhifa, et al.. (2023). Transient increase in platelet counts associated with COVID‐19 infection during TPO‐RA as the second‐line treatment in children with ITP. British Journal of Haematology. 203(3). 384–388. 2 indexed citations
10.
Wang, Zhifa, Nan Wang, Jingjing Liu, et al.. (2023). Long‐term eltrombopag in children with chronic immune thrombocytopenia: A single‐centre extended real‐life observational study in China. British Journal of Haematology. 204(3). 1017–1023. 3 indexed citations
11.
Li, Zekun, Zhenping Chen, Guoqing Liu, et al.. (2023). Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes. Thrombosis Research. 225. 33–38. 5 indexed citations
12.
Wang, Zhifa, Lijuan Wang, Yan Liu, et al.. (2023). Sustained response off treatment in eltrombopag for children with persistent/chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China. British Journal of Haematology. 202(2). 422–428. 9 indexed citations
13.
Li, Gang, et al.. (2022). Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half‐life factor VIII concentrates. Research and Practice in Thrombosis and Haemostasis. 6(2). e12686–e12686. 3 indexed citations
14.
Li, Gang, Yan Wang, Ningning Zhang, et al.. (2022). Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A. Haemophilia. 28(6). e209–e218. 8 indexed citations
15.
Li, Zekun, Guoqing Liu, Zhenping Chen, et al.. (2022). Eradication of FIX inhibitor in haemophilia B children using low‐dose immune tolerance induction with rituximab‐based immunosuppressive agent(s) in China. Haemophilia. 28(4). 625–632. 3 indexed citations
16.
Cheng, Xiaoling, Lingling Fu, Zhenping Chen, et al.. (2021). Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice. Blood Advances. 5(19). 3799–3806. 12 indexed citations
17.
Wu, Runhui, Xiaojing Li, Qing Zhang, et al.. (2021). Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study. Research and Practice in Thrombosis and Haemostasis. 5(6). e12552–e12552. 8 indexed citations
18.
19.
Li, Zekun, Zhenping Chen, Xiaoling Cheng, et al.. (2019). Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China. Research and Practice in Thrombosis and Haemostasis. 3(4). 741–748. 12 indexed citations
20.
Chen, Zhenping, et al.. (2014). Foxp3 methylation status in children with primary immune thrombocytopenia. Human Immunology. 75(11). 1115–1119. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konradin Metze Breakdown of academic impact, for papers by Colin Longstaff Breakdown of academic impact, for papers by Akira Hayakawa Breakdown of academic impact, for papers by Takeshi Sasaki Breakdown of academic impact, for papers by Rongrong Liu Breakdown of academic impact, for papers by Na Wang Breakdown of academic impact, for papers by Takashi Sugihara Breakdown of academic impact, for papers by Claire Summers Breakdown of academic impact, for papers by S. Moore Breakdown of academic impact, for papers by Jacob Odeberg
Rankless by CCL
2026